Faegre Drinker Advises Elevance Health in Acquisition of Paragon Healthcare

A Faegre Drinker team led by insurance M&A partner Jared Danilson and corporate partner Jonathan Nygren represented Elevance Health in its acquisition of Paragon Healthcare, Inc., a company specializing in life-saving and life-giving infusible and injectable therapies.

The deal was announced in January and closed in March. Paragon Healthcare now operates as part of CarelonRx, the pharmacy services segment within Carelon, Elevance Health’s health services division.

A cross-office, cross-practice team of attorneys supported Danilson and Nygren on this deal, including insurance partners Jay Warmuth and Jason Kimpel and associates JT Minor, Hannah Reichenbach Coe, Sergio Gonzalez, John Bloor, Christine Stoddard and Mason Medeiros; corporate partners Kassendra Galindo and Charles Bybee and associate Jennifer Lucas; health care partner Amy Johnson, counsel Jonathan Keller and associate Krissa Webb; antitrust partner Ken Vorrasi and business litigation associate Alison Agnew; intellectual property partners Rob Leonard and Kenneth Dort and associate Joseph Decker; labor and employment partner Nicole Truso, counsel Rhiannon Beckendorf and associates Kristin Halsing and Erik Mosvick; benefits and executive compensation partner Phil Gutwein and counsel Karen Gelula; real estate partner Paul Moe and associate Crystal Thorpe; and government and regulatory associate Charles Westerhaus.

Elevance Health is a lifetime, trusted health partner fueled by its purpose to improve the health of humanity. Read Elevance Health’s press release for more information on the deal.

Results may vary depending on your particular facts and legal circumstances.